Connect with us

Press Releases

Morris Animal Foundation Funds Two Studies Focused on Nonsurgical Cat Sterilization

The first project will be conducted at University of Georgia and the second at Tufts University.

mm

Published

on

(PRESS RELEASE) DENVER – With an estimated 60 million to 100 million free-roaming, community cats in the United States, new strategies are needed that move beyond trap/neuter/release programs. Two studies recently approved by Morris Animal Foundation will tackle this important problem using nonsurgical methods to control reproductive capacity. The first project will be conducted at University of Georgia and the second at Tufts University.

“The importance of finding viable, safe, humane and cost-effective techniques for nonsurgical sterilization in community cats cannot be overstated,” said Dr. Kathy Tietje, vice president of scientific operations at Morris Animal Foundation. “We’re excited about these innovative projects and their impact on population control of this specific group of cats.”

Reducing the number of cats entering the shelter system and improving overall feline health outcomes are the primary drivers behind these new studies. An additional benefit will be reducing the environmental impact of free-roaming, community cats through humane population control.

The projects are slated to begin in 2023. The project at the University of Georgia is aimed at developing an oral vaccine to decrease male cat fertility by reducing reproductive hormone levels. The Tufts University project focuses on decreasing hormone levels in female cats through an injectable medication. The projects are expected to last 12-24 months.

About Morris Animal Foundation

Morris Animal Foundation’s mission is to bridge science and resources to advance the health of animals. Founded in 1948 and headquartered in Denver, it is one of the largest nonprofit animal health research organizations in the world, funding more than $149 million in nearly 3,000 critical studies across a broad range of species. Learn more at morrisanimalfoundation.org.

Advertisement

Advertisement

FEATURED VIDEO

Sponsored by Cogent Solutions Group

Reduce Your Pet’s Hip & Joint Discomfort with the Most Researched Hyaluronan on the Market

Nearly 60% of dogs and 90% of cats suffer from joint discomfort. Trixsyn joint supplement contains a patented and proven hyaluronic acid molecule for maximum efficacy to promote joint, bone, soft tissue, and cartilage health, keeping your pet feeling comfortable, for longer. Trixsyn is veterinarian recommended, safe and all-natural, and contains research-proven ingredients. Get your paws on the most-researched hyaluronic acid on the market. Learn more at Trixsyn.com.

Promoted Headlines

Most Popular